Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

<< < Results 11 - 20 of 27745 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 11782374 Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. causal interaction
diagnostic usage
therapeutic application
unassigned
4
3
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 11911260 Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis. ongoing research
therapeutic application
unassigned
2
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 12148579 Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. ongoing research
unassigned
3
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 14583451 Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. causal interaction
diagnostic usage
ongoing research
unassigned
1
4
1
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 14643021 Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. causal interaction
ongoing research
therapeutic application
unassigned
4
2
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 14971826 Fructooligosaccharide associated with celecoxib reduces the number of aberrant crypt foci in the colon of rats. ongoing research
unassigned
3
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 15069535 Inhibitory effects of etodolac, a selective COX-2 inhibitor, on the occurrence of tumors in colitis-induced tumorigenesis model in rats. causal interaction
ongoing research
therapeutic application
unassigned
3
4
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 15244513 Indian food ingredients and cancer prevention - an experimental evaluation of anticarcinogenic effects of garlic in rat colon. causal interaction
therapeutic application
unassigned
4
3
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 15300575 Glutathione-S-transferase P1-1 protects aberrant crypt foci from apoptosis induced by deoxycholic acid. causal interaction
diagnostic usage
ongoing research
therapeutic application
4
3
4
2
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 15455344 JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats. causal interaction
ongoing research
therapeutic application
unassigned
3
2
3
0
<< < Results 11 - 20 of 27745 > >>